Two commercialized hematology products, Olverembatinib and Lisaftoclax, drive dual-engine growth with strong China market presence Next-generation BTK protein degrader APG-3288…
Innovative full-body flotation system delivers true zero gravity support while launching Spring 2026 give-back initiative for the special-needs community A…